Skip to main content
Erschienen in: Herz 1/2020

25.07.2019 | Original articles

Comparison of MESA of and Framingham risk scores in the prediction of coronary artery disease severity

verfasst von: Dr. Y. Wang, M.D., Dr. Q. Lv, M.D., H. Wu, M.D., K. Chen, M.D., X. Hong, M.D., C. Gu, M.D., Dr. G. Fu, Ph.D. M.D., Dr. W. Zhang, Ph.D. M.D.

Erschienen in: Herz | Sonderheft 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The correlation between cardiovascular risk scoring systems and the severity of coronary artery diseases (CAD) is not clear. The present research aimed to evaluate the Multi-Ethnic Study of Atherosclerosis (MESA) risk score and Framingham risk score (FRS), using the Gensini score (GS) system as reference, so as to determine which model is better for the prediction of CAD severity.

Methods

This research was a single-center and cross-sectional observational study. In total, 1423 patients were included in our study. Three different groups were formed according to GS: 0 < GS ≤ 22 (low GS group, n = 484); 22 < GS ≤ 42 (intermediate GS group, n = 468); GS > 42 (high GS group, n = 471). Logistic and linear regression analyses were carried out to explore the relationship between the risk score models and the GS. The performance of the risk models was determined by receiver operating characteristic curve (ROC) analysis.

Results

The MESA risk score and the FRS both had a statistically significant power for the prediction of CAD severity (MESA area under curve: 0.630; FRS area under curve: 0.613). Furthermore, the MESA had a better performance in predicting the severity (p < 0.05) of CAD compared with the FRS. In the subgroup analysis, the MESA showed a better performance in the male (p < 0.05), diabetes mellitus (p < 0.05), and smoking subgroups (p < 0.05) compared with the FRS.

Conclusion

The MESA and FRS predicted the severity of CAD in the Chinese population of this study. Moreover, the MESA had a better performance than the FRS model in predicting the severity of CAD in the overall population as well as in the male, smoking, diabetes, and non-diabetes subgroups.
Literatur
1.
Zurück zum Zitat GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117–171. https://doi.org/10.1016/S0140-6736(14)61682-2CrossRef GBD 2013 Mortality and Causes of Death Collaborators (2015) Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117–171. https://​doi.​org/​10.​1016/​S0140-6736(14)61682-2CrossRef
9.
Zurück zum Zitat Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606CrossRef Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606CrossRef
15.
Zurück zum Zitat Acet H, Ertaş F, Bilik MZ, Aydın M, Yüksel M, Polat N, Yıldız A, Özyurtlu F, Akıl MA, Çiftçi L, Özbek M, Alan S, Toprak N (2015) The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary intervention. Ther Adv Cardiovasc Dis 9(5):257–266. https://doi.org/10.1177/1753944715574814CrossRefPubMed Acet H, Ertaş F, Bilik MZ, Aydın M, Yüksel M, Polat N, Yıldız A, Özyurtlu F, Akıl MA, Çiftçi L, Özbek M, Alan S, Toprak N (2015) The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary intervention. Ther Adv Cardiovasc Dis 9(5):257–266. https://​doi.​org/​10.​1177/​1753944715574814​CrossRefPubMed
17.
Metadaten
Titel
Comparison of MESA of and Framingham risk scores in the prediction of coronary artery disease severity
verfasst von
Dr. Y. Wang, M.D.
Dr. Q. Lv, M.D.
H. Wu, M.D.
K. Chen, M.D.
X. Hong, M.D.
C. Gu, M.D.
Dr. G. Fu, Ph.D. M.D.
Dr. W. Zhang, Ph.D. M.D.
Publikationsdatum
25.07.2019
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe Sonderheft 1/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-019-4838-z

Weitere Artikel der Sonderheft 1/2020

Herz 1/2020 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.